Abbvie Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abbvie Inc with three other
companies in this sector in the United States:
sales of $22.47 billion
of which 100%
Eli Lilly and Company
of which 44%
was Human pharmaceutical products - Endocrin), and
of which 33%
was Vascular Products).
During the year ended December of 2017, sales at
Abbvie Inc were $28.22 billion.
increase of 10.1%
versus 2016, when the company's sales were $25.64 billion.
This was the fifth consecutive year of sales increases at Abbvie Inc
(and since 2012, sales have increased a total of 54%).